SCHEMBL4650804

SCHEMBL4650804

Cc1occc1C(=O)Nc1ccccc1B(O)O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.77
ESR2 Q92731 1/20 0.77
RAB9A P51151 6/20 0.66
SMN1; SMN2 Q16637 6/20 0.66
NPC1 O15118 5/20 0.66
ALDH1A1 P00352 3/20 0.66
TP53 P04637 3/20 0.66
KMT2A Q03164 3/20 0.66
NFKB1 P19838 2/20 0.66
NFKB2 Q00653 2/20 0.66
RELA Q04206 2/20 0.66
MEN1 O00255 2/20 0.66
GAA P10253 2/20 0.66
POLB P06746 5/20 0.60
HSD17B10 Q99714 3/20 0.53
USP2 O75604 1/20 0.53
LMNA P02545 1/20 0.53
ALOX15 P16050 1/20 0.53
HTT P42858 1/20 0.52
TSHR P16473 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14579796 0.90 MAPK1 (0.75) MAPK1ESR2RAB9ASMN1; SMN2NPC1
SCHEMBL8930036 0.82 MAPK1 (0.82) MAPK1ESR2RAB9ASMN1; SMN2NPC1
SCHEMBL4650780 0.81 MAPK1 (0.79) MAPK1ESR2RAB9ASMN1; SMN2NPC1
SCHEMBL4652064 0.78 MAPK1 (0.75) MAPK1ESR2RAB9ASMN1; SMN2NPC1
Fenfuram SCHEMBL18978 0.76 SMN1; SMN2 (0.73) MAPK1ESR2RAB9ASMN1; SMN2NPC1
SCHEMBL13645619 0.75 MAPK1 (0.69) MAPK1ESR2RAB9ASMN1; SMN2NPC1
SCHEMBL14579829 0.74 MAPK1 (0.68) MAPK1ESR2RAB9ASMN1; SMN2NPC1
SCHEMBL3149525 0.73 RAB9A (0.45) RAB9ASMN1; SMN2NPC1ALDH1A1GAA
SCHEMBL14041225 0.73 MAPK1 (0.61) MAPK1ESR2RAB9ASMN1; SMN2NPC1
SCHEMBL14579830 0.73 MAPK1 (0.66) MAPK1ESR2RAB9ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1513824-B1 FURANCARBOXAMIDES BAYER CROPSCIENCE AG (DE) 2008-10-01 EP disclosed
US-7179840-B2 Furancarboxamides BAYER CROPSCIENCE AG (DE) 2007-02-20 US disclosed
US-7179840-B2 Furancarboxamides BAYER CROPSCIENCE AG (DE) 2007-02-20 US disclosed
US-7179840-B2 Furancarboxamides BAYER CROPSCIENCE AG (DE) 2007-02-20 US disclosed
US-20060142381-A1 Furancarboxamides BAYER INTELLECTUAL PROPERTY GMBH (DE) 2006-06-29 US disclosed
EP-1513824-A1 FURANCARBOXAMIDES Bayer CropScience AG (DE) 2005-03-16 EP disclosed
WO-2003099803-A1 FURANCARBOXAMIDES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2003-12-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060142381-A1 Furancarboxamides DDT, MRM1, FPR1 MAPK1 3713/4885ESR2 2380/4885RAB9A 3112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.